TR200003198T2 - sPLA2 önleyicisi ester - Google Patents

sPLA2 önleyicisi ester

Info

Publication number
TR200003198T2
TR200003198T2 TR2000/03198T TR200003198T TR200003198T2 TR 200003198 T2 TR200003198 T2 TR 200003198T2 TR 2000/03198 T TR2000/03198 T TR 2000/03198T TR 200003198 T TR200003198 T TR 200003198T TR 200003198 T2 TR200003198 T2 TR 200003198T2
Authority
TR
Turkey
Prior art keywords
spla2 inhibitor
inhibitor ester
ester
spla2
dioxoethyl
Prior art date
Application number
TR2000/03198T
Other languages
English (en)
Turkish (tr)
Inventor
Lyle Denney Michael
John Michael Morin, Jr.
Jon Sall Daniel
Scott Sawyer Jason
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200003198T2 publication Critical patent/TR200003198T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TR2000/03198T 1998-05-01 1999-04-20 sPLA2 önleyicisi ester TR200003198T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8387398P 1998-05-01 1998-05-01

Publications (1)

Publication Number Publication Date
TR200003198T2 true TR200003198T2 (tr) 2001-03-21

Family

ID=22181214

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03198T TR200003198T2 (tr) 1998-05-01 1999-04-20 sPLA2 önleyicisi ester

Country Status (22)

Country Link
EP (1) EP1073440B1 (https=)
JP (1) JP4459441B2 (https=)
KR (1) KR20010071197A (https=)
CN (1) CN1303290A (https=)
AT (1) ATE280155T1 (https=)
AU (1) AU755901B2 (https=)
BR (1) BR9910149A (https=)
CA (1) CA2331036A1 (https=)
DE (1) DE69921314T2 (https=)
EA (1) EA003277B1 (https=)
ES (1) ES2230847T3 (https=)
HR (1) HRP20000738A2 (https=)
HU (1) HUP0201636A1 (https=)
ID (1) ID27812A (https=)
IL (1) IL139203A0 (https=)
NO (1) NO315940B1 (https=)
NZ (1) NZ507391A (https=)
PL (1) PL344571A1 (https=)
SK (1) SK16332000A3 (https=)
TR (1) TR200003198T2 (https=)
WO (1) WO1999056752A1 (https=)
ZA (1) ZA200005561B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140327A (en) * 1999-05-12 2000-10-31 Eli Lilly And Company Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
AU2252201A (en) * 1999-12-16 2001-06-25 Eli Lilly And Company Carbon monoxide-based synthesis of spla2 inhibitors
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
EP1303262A2 (en) * 2000-07-14 2003-04-23 Eli Lilly And Company Use of a spla2 inhibitor for the treatment of sepsis
US8048880B2 (en) 2007-05-03 2011-11-01 Anthera Pharmaceuticals, Inc. Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapies
CN101742907A (zh) * 2007-05-03 2010-06-16 安塞拉制药有限公司 采用分泌型磷脂酶a2（spla2）抑制剂和spla2抑制剂组合疗法治疗心血管疾病和血脂异常
US20150335498A1 (en) * 2014-05-22 2015-11-26 The Procter & Gamble Company Heterogenous mass containing foam
US10729600B2 (en) 2015-06-30 2020-08-04 The Procter & Gamble Company Absorbent structure
CA3004313A1 (en) 2015-11-04 2017-05-11 The Procter & Gamble Company Absorbent structure
US11173078B2 (en) 2015-11-04 2021-11-16 The Procter & Gamble Company Absorbent structure
EP3370664B1 (en) 2015-11-04 2022-01-26 The Procter & Gamble Company Absorbent article comprising an absorbent structure

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2036307C (en) * 1990-03-08 2002-07-09 Susan Jean Ward 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method
BR9501404A (pt) * 1994-04-01 1996-03-05 Lilly Co Eli 1H-indol-3 glioxilamida e formulação farmacèutica
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
FI974437A7 (fi) * 1995-06-06 1997-12-05 Pfizer Substituoituja N-(indoli-2-karbonyyli)amideja ja johdannaisia glykogee nifosforylaasi-inhibiittoreina
JP2002542148A (ja) * 1998-12-21 2002-12-10 イーライ・リリー・アンド・カンパニー 敗血症の処置のための組み合わせ療法

Also Published As

Publication number Publication date
ATE280155T1 (de) 2004-11-15
EA003277B1 (ru) 2003-04-24
JP2002513761A (ja) 2002-05-14
PL344571A1 (en) 2001-11-05
HRP20000738A2 (en) 2001-10-31
KR20010071197A (ko) 2001-07-28
BR9910149A (pt) 2001-10-02
ZA200005561B (en) 2002-01-10
IL139203A0 (en) 2001-11-25
CN1303290A (zh) 2001-07-11
CA2331036A1 (en) 1999-11-11
ID27812A (id) 2001-04-26
DE69921314T2 (de) 2006-02-09
WO1999056752A1 (en) 1999-11-11
NO315940B1 (no) 2003-11-17
EP1073440B1 (en) 2004-10-20
AU3652599A (en) 1999-11-23
SK16332000A3 (sk) 2001-06-11
EP1073440A4 (en) 2002-07-17
HUP0201636A1 (en) 2002-09-28
NO20005477D0 (no) 2000-10-31
AU755901B2 (en) 2003-01-02
JP4459441B2 (ja) 2010-04-28
NO20005477L (no) 2000-10-31
DE69921314D1 (de) 2004-11-25
NZ507391A (en) 2003-12-19
ES2230847T3 (es) 2005-05-01
EP1073440A1 (en) 2001-02-07
EA200001141A1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
TR200003198T2 (tr) sPLA2 önleyicisi ester
DK1950200T3 (da) [[3-(2-AMINO-1,2-DIOXOETHYL)-2-ETHYL-1-(PHENYLMETHYL)-11H-INDOL-4-YL]OXY]EDDIKESYREMETHYLESTER SOM sPLA2-INHIBITOR
ATE296286T1 (de) Morpholino-n-ethyl ester prodrogen von indol spla 2 hemmer
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
Kojima et al. A new and highly sensitive fluorescence assay for collagenase-like peptidase activity
ATE422895T1 (de) Makrocyclische isochinolinpeptidinhibitoren des hepatitis-c-virus
TW200736374A (en) Polishing composition and polishing method
PL365668A1 (en) Inhibitors of alpha4 mediated cell adhesion
TR200200129T2 (tr) Hepatit C inhibitörü tri-peptidler
ATE343383T1 (de) Hemmer der zelladhäsion
TR200102908T2 (tr) alfa-İkameli karboksilik asit türevleri
TR200101874T1 (tr) Sitalopram hazırlanması için yöntem
DK51087A (da) Antihypercholesterolaemiske forbindelser
AP2002002554A0 (en) Ox (ADI) azolyl-hydroxamic acids useful as procollagen C- proteinase inhibitors.
TR200002543T2 (tr) Fosfolipaz önleyici sodyum [[3-(2-amino-1,2-dioksietil-1-fenilmetil) -2-etil-1-fenilmetil)- 1H-indol-4-il]oksi] asetat içeren farmasötik kompozisyonlar
JP2002513761A5 (https=)
AU3602499A (en) Indole derivatives suitable to be used as chromogenic compounds
BR0010448A (pt) éster de morfolino-n-etila derivado de um inibidor de spla2 de indol
TR199901891A2 (xx) Alfa-Ketokarboksilik esterlerin transesterle�tirilmesine ili�kin proses.
TR200200995T2 (tr) 7-amino-3-metksimetil-3-sefem-4-karbosilik asitin hazırlanmasına yönelik proses.
TR200401456T1 (tr) Sitalopram hazırlanması için yöntem.
JPH10227755A5 (https=)
AU5209600A (en) Orally active androgens
CO5560539A2 (es) Derivados de 2-hidroxi-2-metil-3,3,3-trifluoropropanamida n-fenilo sustituida que elevan la actividad de piruvato deshidrogenasa
IE863094L (en) Indolopyridines